Smart Eyewear to Automatically Detect Drug Delivery Events
University of Washington · NCT05184660
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 20
- US sites recruiting
- 1
- Study start
- January 4, 2021
- Record last updated
- May 8, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This project is designed as a prospective observational study of medication preparation and delivery using a novel wearable data input device to automate detection of drug delivery events in the anesthesia workspace at University of Washington Medical Center.
Conditions: Smart Eyewear
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Anesthesia providers (attending anesthesiologist or certified registered nurse anesthetist) who work in an operating room at University of Washington Montlake Medical Center
Exclusion Criteria
- Medical students and anesthesiology residents
Recruiting US locations
University of Washington
Seattle, WA 98195
Site contact: Kelly Michaelsen, MD, PhD · 716-908-5411 · kellyem@uw.edu
Study contacts (from the official record)
- Kelly Michaelsen, MD, PhD · 7169085411 · kellyem@uw.edu
- Sharon T Nguyen, BS · 2066188673 · sharon17@uw.edu
Similar studies in Washington
All healthy volunteers studies in Washington →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Seattle, WA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
GlaxoSmithKline
- Location
- Seattle, WA + 2 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
GlaxoSmithKline
- Location
- Seattle, WA + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Vega Therapeutics, Inc
- Location
- Seattle, WA + 9 other US sites
- Eligibility basics
- Ages 12–60